Form 4 for DGX Quest Diagnostics
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-24 · accession 0001022079-23-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-27 | 2023-03-24 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | F - Tax | $134.25 | -170 | 3,480 | -5% | -$22.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | F | D | 170 | $134.25 | 3,480 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. |